Literature DB >> 7657609

Accurate modification of the trypanosome spliced leader cap structure in a homologous cell-free system.

E Ullu1, C Tschudi.   

Abstract

During RNA maturation in trypanosomatid protozoa, trans-splicing transfers the spliced leader (SL) sequence and its cap from the SL RNA to the 5' end of all mRNAs. In Trypanosoma brucei and Crithidia fasciculata the SL RNA has an unusual cap structure with four methylated nucleotides following the 7-methylguanosine residue (cap 4). Since modification of the 5' end of the SL RNA is a pre-requisite for trans-splicing activity in T. brucei, we have begun to characterize the enzyme(s) involved in this process. Here we report the development of a T. brucei cell-free system for modification of the cap of the SL RNA. Analysis of the nucleotide composition of the in vitro generated cap structure by two-dimensional thin layer chromatography established that the in vitro reaction is accurate. Cap 4 formation requires the SL RNA to be in a ribonucleoprotein particle and can be inhibited by annealing a complementary 2'-O-methyl RNA oligonucleotide to nucleotides 7-18 of the SL RNA. Methylation of the 5' end of the SL RNA is also required for trans-splicing in T. cruzi and Leishmania amazonensis and cell-free extracts from C. fasciculata and L. amazonensis are capable of modifying the cap structure on the T. brucei SL ribonucleoprotein particle.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7657609     DOI: 10.1074/jbc.270.35.20365

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

Review 1.  Unconventional rules of small nuclear RNA transcription and cap modification in trypanosomatids.

Authors:  Christian Tschudi; Elisabetta Ullut
Journal:  Gene Expr       Date:  2002

Review 2.  trans and cis splicing in trypanosomatids: mechanism, factors, and regulation.

Authors:  Xue-hai Liang; Asaf Haritan; Shai Uliel; Shulamit Michaeli
Journal:  Eukaryot Cell       Date:  2003-10

3.  Chemical synthesis and binding activity of the trypanosomatid cap-4 structure.

Authors:  Magdalena Lewdorowicz; Yael Yoffe; Joanna Zuberek; Jacek Jemielity; Janusz Stepinski; Ryszard Kierzek; Ryszard Stolarski; Michal Shapira; Edward Darzynkiewicz
Journal:  RNA       Date:  2004-07-23       Impact factor: 4.942

Review 4.  Enzymology of RNA cap synthesis.

Authors:  Agnidipta Ghosh; Christopher D Lima
Journal:  Wiley Interdiscip Rev RNA       Date:  2010-05-25       Impact factor: 9.957

5.  Complete cap 4 formation is not required for viability in Trypanosoma brucei.

Authors:  Jesse R Zamudio; Bidyottam Mittra; Gusti M Zeiner; Marcin Feder; Janusz M Bujnicki; Nancy R Sturm; David A Campbell
Journal:  Eukaryot Cell       Date:  2006-06

6.  The 2'-O-ribose methyltransferase for cap 1 of spliced leader RNA and U1 small nuclear RNA in Trypanosoma brucei.

Authors:  Jesse R Zamudio; Bidyottam Mittra; Silvie Foldynová-Trantírková; Gusti M Zeiner; Julius Lukes; Janusz M Bujnicki; Nancy R Sturm; David A Campbell
Journal:  Mol Cell Biol       Date:  2007-07-02       Impact factor: 4.272

7.  A protein related to the vaccinia virus cap-specific methyltransferase VP39 is involved in cap 4 modification in Trypanosoma brucei.

Authors:  George K Arhin; Hongjie Li; Elisabetta Ullu; Christian Tschudi
Journal:  RNA       Date:  2005-11-21       Impact factor: 4.942

8.  Physical and transcriptional analysis of the Trypanosoma brucei genome reveals a typical eukaryotic arrangement with close interspersionof RNA polymerase II- and III-transcribed genes.

Authors:  M A Marchetti; C Tschudi; E Silva; E Ullu
Journal:  Nucleic Acids Res       Date:  1998-08-01       Impact factor: 16.971

9.  Transcription termination and 3'-End processing of the spliced leader RNA in kinetoplastids.

Authors:  N R Sturm; M C Yu; D A Campbell
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

10.  Cap-binding activity of an eIF4E homolog from Leishmania.

Authors:  Yael Yoffe; Joanna Zuberek; Magdalena Lewdorowicz; Ziv Zeira; Chen Keasar; Irit Orr-Dahan; Marzena Jankowska-Anyszka; Janusz Stepinski; Edward Darzynkiewicz; Michal Shapira
Journal:  RNA       Date:  2004-09-23       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.